APH.TO - Aphria Inc.

Toronto - Toronto Delayed Price. Currency in CAD
10.52
+0.13 (+1.25%)
As of 2:43PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close10.39
Open10.21
Bid10.52 x 0
Ask10.53 x 0
Day's Range10.03 - 10.65
52 Week Range5.71 - 24.75
Volume3,039,593
Avg. Volume4,000,742
Market Cap2.445B
Beta3.99
PE Ratio (TTM)51.07
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • Business Wire3 days ago

    Perennial and Aphria Sign LOI to Establish Joint Venture to Develop New, Consumer-Centric, Cannabis-Infused Products and Brands for the Canadian Market

    Perennial Inc. (“Perennial”), a subsidiary of DATA Communications Management Corp. (DCM.TO) (“DCM”), and Aphria Inc. (TSX:APH and US OTC:APHQF) (“Aphria”) are pleased to announce they have signed a Letter of Intent to form a joint venture (the “JV”) to collaborate on the development of new products, brands and product categories that will drive the evolution of the Canadian adult-use cannabis market. The JV will be powered by Aphria’s best-in-class cannabis production and Perennial’s industry-leading expertise in strategic brand development. As the cannabis industry expands into new and highly-anticipated product categories, Perennial and Aphria believe that a committed, consumer-centric approach will enable the JV to remain on the leading edge of the cannabis industry.

  • Aphria to provide coast-to-coast retail distribution to B.C.-based premium cannabis producer We Grow
    CNW Group9 days ago

    Aphria to provide coast-to-coast retail distribution to B.C.-based premium cannabis producer We Grow

    LEAMINGTON, ON , Aug. 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Manufacturer's Representative agreement (the "Agreement") with We Grow BC Ltd. ("We Grow"), a Vancouver -based licensed producer of premium cannabis, to become We Grow's exclusive sales representative across Canada . The Agreement adds a second brand of premium B.C.-bud to be sold alongside Aphria's expanding portfolio of adult-use brands, which includes celebrated B.C.-bud from Broken Coast Cannabis, through the Company's coast-to-coast sales distribution network. "Aphria has an unmatched ability to offer a cross- Canada sales and distribution network for adult-use cannabis," said Jakob Ripshtein, Chief Commercial Officer at Aphria.

  • ACCESSWIRE16 days ago

    Today's Research Reports on ABcann Global, Medicure, Aphria and Acerus Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / August 1, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group16 days ago

    Aphria Records Revenue Increase of 17% in Quarter and 81% Year Over Year

    Aphria Records Revenue Increase of 17% in Quarter and 81% Year Over Year

  • Aphria Secures $25 Million Loan from WFCU Credit Union
    CNW Group17 days ago

    Aphria Secures $25 Million Loan from WFCU Credit Union

    LEAMINGTON, ON , July 31, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it is has secured $25 million in debt financing from WFCU Credit Union ("WFCU"). This is the second round of debt-financing secured by the Company from WFCU, having previously secured a $25 million five-year loan on May 9, 2017 . "We are delighted to once again have the support of WFCU Credit Union as Aphria continues to execute on its long-term strategic plan," said Vic Neufeld , Chief Executive Officer at Aphria.

  • Aphria Completes Largest Export Shipment to Date to Medlab Australia
    CNW Group22 days ago

    Aphria Completes Largest Export Shipment to Date to Medlab Australia

    LEAMINGTON, ON , July 26, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it completed its largest international shipment of cannabis oil to date to Australian medical life science company, Medlab Clinical Limited ("Medlab") (ASX:MDC). The shipment is part of the previously announced agreement between Aphria and Medlab in which Aphria produces and supplies high-yield cannabis extracts for Medlab to be used in a human trial to test the management of intractable pain in oncology patients – the first trial of its kind globally.

  • Aphria to Announce Fourth Quarter Results on August 1, 2018
    CNW Group23 days ago

    Aphria to Announce Fourth Quarter Results on August 1, 2018

    LEAMINGTON, ON , July 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018 . Financial results are expected to be released at approximately 7:00am ET , through SEDAR and on Aphria's website at aphria.ca/investors. A conference call is scheduled for 9:00am ET and will feature a presentation by Aphria executives followed by a question and answer period with analysts.

  • Aphria provides update on investments
    CNW Group25 days ago

    Aphria provides update on investments

    LEAMINGTON, ON , July 23, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today provided an update related to its previously announced plan to divest of its equity investments in Liberty Health Sciences, Inc. ("Liberty"). "The U.S. cannabis industry continues to gain momentum at the state and federal level, and in public opinion, and we are pleased to retain the optionality to extend our strategic partnership with Liberty in a way that satisfies our obligations as a member of the Toronto Stock Exchange," said Vic Neufeld , Chief Executive Office of Aphria.

  • GlobeNewswirelast month

    Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has entered into a strategic deal with Aphria Inc. It is expected that the Company’s strategic relationship with Aphria will provide leverage for early stage investments in emerging international markets.

  • Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean
    CNW Grouplast month

    Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean

    LEAMINGTON, ON , July 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) is proud to announce the Company's planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia , Argentina , Jamaica and a right of first offer and refusal in respect of Brazil through a definitive share purchase agreement (the "Agreement") with Scythian Biosciences Inc. ("Scythian"). Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc. ("LATAM Holdings"), a direct, wholly-owned subsidiary of Scythian (collectively, the "Transaction").

  • Aphria Signs MOU to Supply More Than 5,000 Kg of Cannabis to British Columbia's Retail Cannabis Market
    CNW Grouplast month

    Aphria Signs MOU to Supply More Than 5,000 Kg of Cannabis to British Columbia's Retail Cannabis Market

    LEAMINGTON, ON , July 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Memorandum of Understanding (the "MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in BC's adult-use market. Under the terms of the MOU, Aphria will supply more than 5,000 kg of high-quality cannabis in the first year of the agreement, which will be made available for sale online and at licensed retailers across the province. Adult-use consumers will be able to choose from a wide-ranging selection of Ontario and BC dried flower, pre-rolls and cannabis oils from the Company's portfolio of adult-use brands.

  • Aphria to Announce Fourth Quarter Results on August 1, 2018
    CNW Grouplast month

    Aphria to Announce Fourth Quarter Results on August 1, 2018

    LEAMINGTON, ON , July 9, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018 . Financial results are expected to be released at approximately 7:00am ET , through SEDAR and on Aphria's website at www.aphria.ca/investors. A conference call will be scheduled for 9:00am ET and will feature a presentation by Aphria executives followed by a question and answer period with analysts.

  • ACCESSWIRElast month

    Today's Research Reports on Medicure, Hamilton Thorne, Resverlogix and Aphria

    NEW YORK, NY / ACCESSWIRE / July 5, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...

  • Aphria Signs Agreement with AGLC to Supply Adult-Use Cannabis to Alberta
    CNW Grouplast month

    Aphria Signs Agreement with AGLC to Supply Adult-Use Cannabis to Alberta

    LEAMINGTON, ON , July 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the "Agreement") with the Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to provide a portfolio of high-quality cannabis and cannabis-derivative products for sale in Alberta's adult-use market.

  • Aphria completes divestiture of its ownership interest in Copperstate Farms, realizes gain of approximately $8.8 million
    CNW Grouplast month

    Aphria completes divestiture of its ownership interest in Copperstate Farms, realizes gain of approximately $8.8 million

    Aphria completes divestiture of its ownership interest in Copperstate Farms, realizes gain of approximately $8.8 million

  • Aphria Signs Supply Agreement with MBLL to Supply Up to 2.7 Million Grams of Cannabis to the Manitoba Adult-Use Market
    CNW Group2 months ago

    Aphria Signs Supply Agreement with MBLL to Supply Up to 2.7 Million Grams of Cannabis to the Manitoba Adult-Use Market

    LEAMINGTON, ON , June 29 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the "Agreement") with the Manitoba Liquor and Lotteries Corporation ("MBLL") to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in Manitoba's adult-use market. "We are thrilled to finalize this Agreement with the MBLL," said Jakob Ripshtein, Chief Commercial Officer at Aphria.

  • CNW Group2 months ago

    Aldershot Resources Ltd. Announces Completion Of Recapitalization, Strategic Investments From Canopy Rivers and Green Acre Capital and Formation of Advisory Committee

    Aldershot Resources Ltd. Announces Completion Of Recapitalization, Strategic Investments From Canopy Rivers and Green Acre Capital and Formation of Advisory Committee

  • Aphria Announces Closing of Bought Deal Financing
    CNW Group2 months ago

    Aphria Announces Closing of Bought Deal Financing

    LEAMINGTON, ON , June 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (APH.TO) (OTCQB:  APHQF) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 21,835,510 common shares (the "Shares") of the Company were sold at a price of $11.85 per Share, for aggregate gross proceeds of $258,750 ,794 (the "Offering"). The Offering was underwritten by a syndicate of underwriters led by Clarus Securities Inc. and included Canaccord Genuity Corp., Cormark Securities Inc., Haywood Securities Inc. and  INFOR Financial Inc. (collectively, the "Underwriters").

  • CNW Group2 months ago

    Aphria's Malta-based subsidiary, ASG Pharma, receives first import license for cannabis issued by the Malta Medicines Authority

    LEAMINGTON, ON , June 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its Malta -based subsidiary ASG Pharma ("ASG"), a high-capacity EU GMP-certified lab, is the recipient of the first import license for medical cannabis issued by the Malta Medicines Authority ("MMA"). The license will allow ASG to import medical cannabis for analytical testing and research and is an important step that will enable ASG to become a cornerstone in testing, research and development of medical cannabis in Europe .

  • CNW Group2 months ago

    Aphria Applauds Passage of Bill C-45, a Historic Milestone for Canada and the Cannabis Industry

    Vic Neufeld , CEO of Aphria, said, "This is a historic milestone for our industry and for our country that will reverberate around the world as Canada solidifies its progressive leadership on cannabis. "Today also represents an important milestone for our business, for which all of us at Aphria have been eagerly awaiting," said Neufeld. Backed by our annualized production capacity of 255,000 kg by early next year, we are well prepared to the meet the anticipated demand in the adult-use market while continuing to serve the ongoing needs of our medical cannabis patients.

  • Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales
    CNW Group2 months ago

    Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales

    LEAMINGTON, ON , June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018 . Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.

  • CNW Group2 months ago

    Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

    Vic Neufeld , CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada . "While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations.

  • CNW Group2 months ago

    IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN

    IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN

  • GlobeNewswire2 months ago

    Aphria Announces $225 Million Bought Deal

    Aphria Inc. (“Aphria” or the “Company”) (APH.TO) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 18,987,400 Common Shares (the “Common Shares”) of the Company at a price of C$11.85 per Common Share (the “Offering Price”) for aggregate gross proceeds to the Company of C$225,000,690 (the “Offering”).

  • CNW Group2 months ago

    IIROC Trading Halt - APH

    IIROC Trading Halt - APH